Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidharth Mehan

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
European Journal of Cell Biology|September 24, 2021
Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctionsRakesh Sahu, Shubham Upadhayay, Sidharth Mehan
Current Molecular Pharmacology|March 1, 2021
Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the BrainNitish Kumar, Nidhi Sharma, Sidharth Mehan
Toxicology Reports|November 26, 2019
Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidenceRamit Sharma, Saloni Rahi, Sidharth Mehan
International Journal of Physiology, Pathophysiology and Pharmacology|December 6, 2018
Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in ratsLakhwinder Singh, Surbhi Rana, Sidharth Mehan
Neural Regeneration Research|April 13, 2017
Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disordersSidharth Mehan, Shaba Parveen, Sanjeev Kalra
Biogerontology|April 25, 2023
The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disordersAradhana Prajapati, Sidharth Mehan, Zuber Khan
Neurotoxicity Research|August 25, 2021
Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative DiseasesAnshuman Singh, Shubham Upadhayay, Sidharth Mehan
Immunopharmacology and Immunotoxicology|May 12, 2026
Rituximab Beyond Oncology: Targeting B-Cell-Mediated Immunomodulatory Therapy in Neurodegenerative and Neuropsychiatric DisordersTrina Saha, Tanya Vats, Sidharth Mehan
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 30, 2018
Understanding multifactorial architecture of Parkinson's disease: pathophysiology to managementRamandeep Kaur, Sidharth Mehan, Shamsher Singh
Metabolic Brain Disease|June 10, 2022
PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult ratsAarti Sharma, Sonalika Bhalla, Sidharth Mehan
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
European Journal of Cell Biology|September 24, 2021
Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctionsRakesh Sahu, Shubham Upadhayay, Sidharth Mehan
Current Molecular Pharmacology|March 1, 2021
Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the BrainNitish Kumar, Nidhi Sharma, Sidharth Mehan
Toxicology Reports|November 26, 2019
Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidenceRamit Sharma, Saloni Rahi, Sidharth Mehan
International Journal of Physiology, Pathophysiology and Pharmacology|December 6, 2018
Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in ratsLakhwinder Singh, Surbhi Rana, Sidharth Mehan
Neural Regeneration Research|April 13, 2017
Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disordersSidharth Mehan, Shaba Parveen, Sanjeev Kalra
Biogerontology|April 25, 2023
The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disordersAradhana Prajapati, Sidharth Mehan, Zuber Khan
Neurotoxicity Research|August 25, 2021
Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative DiseasesAnshuman Singh, Shubham Upadhayay, Sidharth Mehan
Immunopharmacology and Immunotoxicology|May 12, 2026
Rituximab Beyond Oncology: Targeting B-Cell-Mediated Immunomodulatory Therapy in Neurodegenerative and Neuropsychiatric DisordersTrina Saha, Tanya Vats, Sidharth Mehan
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 30, 2018
Understanding multifactorial architecture of Parkinson's disease: pathophysiology to managementRamandeep Kaur, Sidharth Mehan, Shamsher Singh
Metabolic Brain Disease|June 10, 2022
PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult ratsAarti Sharma, Sonalika Bhalla, Sidharth Mehan
Pageof 13